United States

Products

In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world.

ProductDescriptionAdditional info
   
Afluria®, Influenza Vaccine
Important Safety Information
Prescribing Information
AFLURIA is an inactivated (virus is not alive) trivalent influenza vaccine indicated for immunization against influenza disease caused by influenza virus subtypes A and B present in the vaccine. Afluria website
   
Afluria Quadrivalent®, Influenza Vaccine
Important Safety Information
Prescribing Information
AFLURIA QUADRIVALENT is an inactivated (virus is not alive) trivalent influenza vaccine indicated for immunization against influenza disease caused by influenza virus subtypes A and B present in the vaccine.  
   
Fluad, Influenza Vaccine, Adjuvanted
Important Safety Information
Prescribing Information
FLUAD is an inactivated adjuvanted trivalent influenza vaccine indicated for active immunization against influenza disease caused by influenza subtypes A and type B contained in the vaccine.Fluad website
   
Flucelvax Quadrivlent®, Influenza Vaccine
Important Safety Information
Prescribing Information
FLUCELVAX QUADRIVALENT is an inactivated cell-based influenza vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.Flucelvax website
   
Fluvirin®, Influenza Vaccine
Important Safety Information
Prescribing Information
FLUVIRIN is a trivalent, inactivated subunit influenza virus vaccine, indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. Fluvirin Website
   
Rapivab, Peramivir Injection
Important Safety Information
Prescribing Information
RAPIVAB is indicated for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than 2 days.Rapivab website
   

The information presented on this site is intended for US residents only.
© 2017 Seqirus All rights reserved.
Seqirus is a trademark of CSL Limited.

BCSL14-02-0003 06/2014